DE PONTI, FABRIZIO
DE PONTI, FABRIZIO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Using artificial intelligence to create diverse and inclusive medical case vignettes for education
In corso di stampa Bakkum, Michiel J; Hartjes, Mariëlle G; Piët, Joost D; Donker, Erik M; Likic, Robert; Sanz, Emilio; de Ponti, Fabrizio; Verdonk, Petra; Richir, Milan C; van Agtmael, Michiel A; Tichelaar, Jelle
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
2024 Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E.
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation
2024 Piët J.D.; Booth A.; Donker E.M.; de Ponti F.; Lunghi C.; Poluzzi E.; Janssen B.J.A.; Tun S.Y.M.; Bekker C.; Dima L.; Costa J.; Jalving M.; Oude Munnink T.H.; van den Bemt P.M.L.A.; Labriffe M.; van Emden T.; van Waardenburg V.; Likic R.; Richir M.; van Agtmael M.A.; Moermond C.T.A.; Tichelaar J.
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward
2024 Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F.
The European List of Key Medicines for Medical Education: A Modified Delphi Study
2024 Donker, Erik M; Spitaleri Timpone, Pietro; Brinkman, David J; Richir, Milan C; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; De Ponti, Fabrizio; Gatti, Milo; Böttiger, Ylva; Kramers, Cornelis; Pandit, Rahul; van Agtmael, Michiel A; Tichelaar, Jelle
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity
2023 Bakkum, Michiel J; Verdonk, Petra; Thomas, Elias G; van Rosse, Floor; Okorie, Michael; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; Dima, Lorena; de Ponti, Fabrizio; van Smeden, Jeroen; van Agtmael, Michiel A; Richir, Milan C; Tichelaar, Jelle
Antipsychotics and Drug-Induced Liver Injury
2023 Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; De Ponti, Fabrizio
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System
2023 Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E.
Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project
2023 Bakkum, Michiel J; Donker, Erik M; Spitaleri Timpone, Pietro; Hagen, Charlotte A M; Richir, Milan C; van Agtmael, Michiel A; De Ponti, Fabrizio; Tichelaar, Jelle
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
2023 Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M.; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E.
Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice
2023 Raschi, Emanuel; Poluzzi, Elisabetta; De Ponti, Fabrizio
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
2022 Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J.; Poluzzi E.
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems
2022 Gatti M.; Fusaroli M.; Raschi E.; Capelli I.; Poluzzi E.; De Ponti F.
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction
2022 Raschi E.; Diemberger I.; Sabatino M.; Poluzzi E.; De Ponti F.; Potena L.
Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants
2022 Martini, Silvia; Vitali, Francesca; Capelli, Irene; Donadei, Chiara; Raschi, Emanuel; Aiello, Valeria; Corvaglia, Luigi; De Ponti, Fabrizio; Poluzzi, Elisabetta; Galletti, Silvia
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System
2022 Fusaroli M.; Raschi E.; Giunchi V.; Menchetti M.; Rimondini Giorgini R.; De Ponti F.; Poluzzi E.
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal
2022 Raschi, Emanuel; Fusaroli, Michele; Gatti, Milo; Caraceni, Paolo; Poluzzi, Elisabetta; De Ponti, Fabrizio
QT prolongation with anticancer drugs: a multimodal issue
2022 Raschi, Emanuel; Poluzzi, Elisabetta; Ponti, Fabrizio De
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System
2022 Raschi E.; Fusaroli M.; La Placa M.; Ardizzoni A.; Zamagni C.; Poluzzi E.; De Ponti F.
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People
2022 Lunghi C.; Trevisan C.; Fusaroli M.; Giunchi V.; Raschi E.; Sangiorgi E.; Domenicali M.; Volpato S.; De Ponti F.; Poluzzi E.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Using artificial intelligence to create diverse and inclusive medical case vignettes for education | Bakkum, Michiel J; Hartjes, Mariëlle G; Piët, Joost D; Donker, Erik M; Likic, Robert; Sanz, Emili...o; de Ponti, Fabrizio; Verdonk, Petra; Richir, Milan C; van Agtmael, Michiel A; Tichelaar, Jelle | 9999-01-01 | BJCP. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | Brit J Clinical Pharma - 2023 - Bakkum.pdf |
| Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals | Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Lunghi et al. Drug Safety 2024.pdf; 40264_2024_1453_MOESM1_ESM.pdf |
| Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation | Piët J.D.; Booth A.; Donker E.M.; de Ponti F.; Lunghi C.; Poluzzi E.; Janssen B.J.A.; Tun S.Y.M.;... Bekker C.; Dima L.; Costa J.; Jalving M.; Oude Munnink T.H.; van den Bemt P.M.L.A.; Labriffe M.; van Emden T.; van Waardenburg V.; Likic R.; Richir M.; van Agtmael M.A.; Moermond C.T.A.; Tichelaar J. | 2024-01-01 | THE LANCET. PLANETARY HEALTH | - | 1.04 Replica / breve intervento (e simili) | - |
| Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward | Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F. | 2024-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| The European List of Key Medicines for Medical Education: A Modified Delphi Study | Donker, Erik M; Spitaleri Timpone, Pietro; Brinkman, David J; Richir, Milan C; Papaioannidou, Par...askevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; De Ponti, Fabrizio; Gatti, Milo; Böttiger, Ylva; Kramers, Cornelis; Pandit, Rahul; van Agtmael, Michiel A; Tichelaar, Jelle | 2024-01-01 | CLINICAL PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | Clin Pharma and Therapeutics_2024.pdf |
| A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity | Bakkum, Michiel J; Verdonk, Petra; Thomas, Elias G; van Rosse, Floor; Okorie, Michael; Papaioanni...dou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; Dima, Lorena; de Ponti, Fabrizio; van Smeden, Jeroen; van Agtmael, Michiel A; Richir, Milan C; Tichelaar, Jelle | 2023-01-01 | CLINICAL PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | Clin Pharma and Therapeutics - 2022 - Bakkum - A Clinical Pharmacology and Therapeutics Teacher s Guide to Race‐Based.pdf |
| Antipsychotics and Drug-Induced Liver Injury | Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; ...De Ponti, Fabrizio | 2023-01-01 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System | Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Pont...i F.; Pelotti S.; Poluzzi E. | 2023-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-022-01269-x.pdf; 40264_2022_1269_MOESM1_ESM.pdf |
| Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project | Bakkum, Michiel J; Donker, Erik M; Spitaleri Timpone, Pietro; Hagen, Charlotte A M; Richir, Milan... C; van Agtmael, Michiel A; De Ponti, Fabrizio; Tichelaar, Jelle | 2023-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study | Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M....; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E. | 2023-01-01 | PSYCHIATRY AND CLINICAL NEUROSCIENCES | - | 1.01 Articolo in rivista | Exploring the underlying mechanisms of drug-induced impulse control disorders a pharmacovigilance-pharmacodynamic study.pdf |
| Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice | Raschi, Emanuel; Poluzzi, Elisabetta; De Ponti, Fabrizio | 2023-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System | Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J....; Poluzzi E. | 2022-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Amyotrophic.pdf |
| Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems | Gatti M.; Fusaroli M.; Raschi E.; Capelli I.; Poluzzi E.; De Ponti F. | 2022-01-01 | JN. JOURNAL OF NEPHROLOGY | - | 1.01 Articolo in rivista | 40620_2021_1191_MOESM2_ESM.pptx; 40620_2021_1191_MOESM1_ESM.pptx |
| Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction | Raschi E.; Diemberger I.; Sabatino M.; Poluzzi E.; De Ponti F.; Potena L. | 2022-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.01 Articolo in rivista | - |
| Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants | Martini, Silvia; Vitali, Francesca; Capelli, Irene; Donadei, Chiara; Raschi, Emanuel; Aiello, Val...eria; Corvaglia, Luigi; De Ponti, Fabrizio; Poluzzi, Elisabetta; Galletti, Silvia | 2022-01-01 | PEDIATRIC RESEARCH | - | 1.01 Articolo in rivista | - |
| Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System | Fusaroli M.; Raschi E.; Giunchi V.; Menchetti M.; Rimondini Giorgini R.; De Ponti F.; Poluzzi E. | 2022-01-01 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | pyac031-10.pdf; pyac031_suppl_supplementary_material.pdf |
| Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal | Raschi, Emanuel; Fusaroli, Michele; Gatti, Milo; Caraceni, Paolo; Poluzzi, Elisabetta; De Ponti, ...Fabrizio | 2022-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | 144_DILI_Nintedanib_Pharmaceuticals_2022.pdf |
| QT prolongation with anticancer drugs: a multimodal issue | Raschi, Emanuel; Poluzzi, Elisabetta; Ponti, Fabrizio De | 2022-01-01 | THE LANCET ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System | Raschi E.; Fusaroli M.; La Placa M.; Ardizzoni A.; Zamagni C.; Poluzzi E.; De Ponti F. | 2022-01-01 | AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | - | 1.01 Articolo in rivista | - |
| Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People | Lunghi C.; Trevisan C.; Fusaroli M.; Giunchi V.; Raschi E.; Sangiorgi E.; Domenicali M.; Volpato ...S.; De Ponti F.; Poluzzi E. | 2022-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | Lunghi-Trevisan 2022 Pharmaceuticals.pdf |